161 related articles for article (PubMed ID: 19136695)
1. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus.
McCormick CC; Caballero AR; Balzli CL; Tang A; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2848-54. PubMed ID: 19136695
[TBL] [Abstract][Full Text] [Related]
2. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
O'Callaghan RJ; McCormick CC; Caballero AR; Marquart ME; Gatlin HP; Fratkin JD
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5125-31. PubMed ID: 17962465
[TBL] [Abstract][Full Text] [Related]
3. Corneal pathogenesis of Staphylococcus aureus strain Newman.
Dajcs JJ; Austin MS; Sloop GD; Moreau JM; Hume EB; Thompson HW; McAleese FM; Foster TJ; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1109-15. PubMed ID: 11923253
[TBL] [Abstract][Full Text] [Related]
4. Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin.
Weeks AC; Balzli CL; Caballero A; Tang A; O'Callaghan R
Curr Eye Res; 2012 Feb; 37(2):87-93. PubMed ID: 22050601
[TBL] [Abstract][Full Text] [Related]
5. Reactions with Antisera and Pathological Effects of Staphylococcus aureus Gamma-Toxin in the Cornea.
Bierdeman MA; Torres AM; Caballero AR; Tang A; O'Callaghan RJ
Curr Eye Res; 2017 Aug; 42(8):1100-1107. PubMed ID: 28346009
[TBL] [Abstract][Full Text] [Related]
6. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus infection of the rabbit cornea following topical administration.
Tang A; Balzli CL; Caballero AR; McCormick CC; Taylor SD; O'Callaghan RJ
Curr Eye Res; 2012 Dec; 37(12):1075-83. PubMed ID: 22916736
[TBL] [Abstract][Full Text] [Related]
8. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
Dajcs JJ; Thibodeaux BA; Girgis DO; O'Callaghan RJ
DNA Cell Biol; 2002; 21(5-6):375-82. PubMed ID: 12167239
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus corneal virulence in a new topical model of infection.
Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus Alpha-Toxin Action on the Rabbit Iris: Toxic Effects and Their Inhibition.
Arana AM; Bierdeman MA; Balzli CL; Tang A; Caballero AR; Patel R; O'Callaghan RJ
Curr Eye Res; 2015; 40(8):830-8. PubMed ID: 25266876
[TBL] [Abstract][Full Text] [Related]
11. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Infect Immun; 1994 Jun; 62(6):2478-82. PubMed ID: 8188373
[TBL] [Abstract][Full Text] [Related]
12. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas.
Moreau JM; Sloop GD; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1997 Dec; 16(12):1221-8. PubMed ID: 9426955
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-toxin-deficient Staphylococcus aureus on the production of peripheral corneal ulceration in an animal model.
Wu PZ; Zhu H; Stapleton F; Hume E; Aliwarga Y; Thakur A; Willcox MD
Curr Eye Res; 2005 Jan; 30(1):63-70. PubMed ID: 15875366
[TBL] [Abstract][Full Text] [Related]
14. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection.
O'Callaghan RJ; Callegan MC; Moreau JM; Green LC; Foster TJ; Hartford OM; Engel LS; Hill JM
Infect Immun; 1997 May; 65(5):1571-8. PubMed ID: 9125532
[TBL] [Abstract][Full Text] [Related]
15. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
Oksuz H; Duran N; Tamer C; Cetin M; Silici S
Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy.
Rao SN; Fong Y; Kampmeier J; LaBree LD; Tanzer DJ; McDonnell PJ
Am J Ophthalmol; 2000 Jul; 130(1):20-4. PubMed ID: 11004255
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes.
Girgis DO; Dajcs JJ; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):197-202. PubMed ID: 12506075
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.
Marquart ME; Monds KS; McCormick CC; Dixon SN; Sanders ME; Reed JM; McDaniel LS; Caballero AR; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2661-6. PubMed ID: 17525197
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
20. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
